Dr. Ruben Kalra recently joined the founder and CEO of Neurovations, Dr. Eric Grigsby to share timely and relevant tips on how to stay afloat as an independent medical practice during COVID-19. “The Fight for Survival” focused on telehealth strategies for patient and practice reimbursement and included the prudent monitoring of patients at risk of […]
Brief Updates on Topics for Pain Management
The Neurovations family of businesses is committed to ensuring digital accessibility for people with disabilities. We are continually improving the user experience for everyone and applying the relevant accessibility standards. We are taking strong measures to ensure accessibility to all of our websites, pages, and forms. Our goal is to meet or exceed Web Content […]
CEO and Founder of Neurovations Honored as Patient Champion NAPA, Calif., October 16, 2019 (Newswire.com) – Dr. Eric Grigsby was awarded the Visionary Leadership Award at the 6th Annual Business of Pain Medicine Conference in Washington D.C. last week. Dr. Grigsby was honored for recognizing pain as a valid disease and acting as a patient champion, […]
In the world of neurotech research, Case Western Reserve University serves as our inherent “Six Degrees of Kevin Bacon.” In fact, at the 2018 NIC Conference in Minneapolis, our happy hour gathering became an impromptu CWRU reunion. How can it be avoided? With the Neurotree lineage of Thomas Mortimer, Dominique Durand, Warren Grill, Hunter Peckham, […]
In the past, we’ve seen things like bioelectronic medicine defined as the nexus between the molecular target, the signal or neural pathway, and the device – or even more broadly the combination of molecular medicine, neuroscience, and engineering. To Dr. Eric Grigsby, the ultimate trifecta lies at the intersection of patient care, discovery, and innovation. […]
The Napa Pain Institute welcomes Dr. David C. Miller, triple Board Certified in the field of Pain Management and Anesthesiology.
Dr. Czura believes that Neuromodulation: The Science (NTS) builds a deeper understanding of the molecular and cellular mechanisms of neuromodulation, both in nerves and in target organs, is essential to develop more specific and more effective technologies for a broader range of indications.
We spoke with Dr. Roy Hamilton, Associate Professor in the departments of Neurology and Physical Medicine and Rehabilitation at the University of Pennsylvania, where he also directs the Laboratory for Cognition and Neural Stimulation (LCNS). Dr. Hamilton has been engaged in research in the field of brain stimulation since 1998, and has employed transcranial magnetic stimulation […]